Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Hamilton Lane Inc (HLNE.O)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date Stock Price (US$) Price Target (US$) Rating
2022-03-2576.43100.00Buy
2022-04-2074.6887.00Buy
2022-06-1963.9572.00Buy
2022-08-0873.4675.00Neutral
2022-10-1959.1968.00Neutral
2023-01-2375.0074.50Neutral
2023-02-1277.2178.50Neutral
2023-04-1471.9575.00Neutral
2023-07-1886.1188.00Neutral
2023-08-0891.9495.00Neutral
2023-10-1981.6890.00Neutral
2023-11-1389.7093.00Neutral
2024-01-18115.30117.00Neutral
2024-02-12116.62118.00Neutral
2024-04-12110.53120.00Neutral
2024-06-24116.86122.00Neutral
2024-08-20142.80150.00Neutral
2024-10-21179.13185.00Neutral
2024-11-12196.90203.00Neutral
2025-01-14141.14155.00Neutral
2025-02-09167.19175.00Neutral
2025-03-20149.20-No Rating

Disclosures

  • Within the past 12 months, UBS has received compensation for products and services other than investment banking services from this company/entity.
  • UBS Securities LLC makes a market in the securities and/or ADRs of this company.
  • UBS holds a long or short position of 0.5% or more of the listed shares of this company.
Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.